Carlo Maria Girelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlo Maria Girelli has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
Marco Soncini
Digestive Physiopathology Unit ASST Santi Paolo e Carlo, Milan, Italy
8 shared publications- Emanuele Rondonotti
Gastroenterology Unit, Valduce Hospital, Como, Italy
7 shared publications - Antonio Giampiero Russo
Epidemiology Unit, Agency for Health Protection of Milan, Milan, Italy
4 shared publications Giordano Bernasconi
Carlo Maria Girelli, Giordano Bernasconi, Gastroenterology and Digestive Endoscopy Unit, Hospital of Busto Arsizio, 21052 Busto Arsizio (VA), Italy
4 shared publicationsRoberto de Franchis
University of Milan, Milan
4 shared publicationsDario Conte
Universita` degli Studi di Milano
3 shared publications
Latest Publications
- 1 June 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (6) , 818-823
Adherence to European Society of Gastrointestinal Endoscopy recommendations of endoscopists performing small bowel capsule endoscopy in Italy
- 1 June 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (6) , 818-823
Adherence to European Society of Gastrointestinal Endoscopy recommendations of endoscopists performing small bowel capsule endoscopy in Italy
- 1 April 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (4) , 471-483
Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)
- 1 April 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (4) , 471-483
Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)
- 1 October 2017
- Published by Elsevier in Digestive and Liver Disease
- Vol. 49 (10) , 1165
A case report of mysterious bleeding
- 1 October 2017
- Published by Elsevier in Digestive and Liver Disease
- Vol. 49 (10) , 1165
A case report of mysterious bleeding
- Open Access
- 1 January 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 23 (4) , 697-702
Implications of small-bowel transit time in the detection rate of capsule endoscopy: A multivariable multicenter study of patients with obscure gastrointestinal bleeding
To define the role of small-bowel transit time in the detection rate of significant small-bowel lesions. Small-bowel capsule endoscopy records, prospectively collected from 30 participating centers in the Lombardy Registry from October 2011 to December 2013, were included in the study if the clinical indication was obscure gastrointestinal bleeding and the capsule reached the cecum. Based on capsule findings, we created two groups: P2 (significant findings) and P0-1 (normal/negligible findings). Groups were compared for age, gender, small-bowel transit time, type of instrument, modality of capsule performance (outpatients vs inpatients), bowel cleanliness, and center volume. We retrieved and scrutinized 1,433 out of 2,295 capsule endoscopy records (62.4%) fulfilling the inclusion criteria. Patients were 67 ± 15 years old, and 815 (57%) were males. In comparison with patients in the P0-1 group, those in the P2 group (n = 776, 54%) were older (P < 0.0001), had a longer small-bowel transit time (P = 0.0015), and were more frequently examined in low-volume centers (P < 0.001). Age and small-bowel transit time were correlated (P < 0.001), with age as the sole independent predictor on multivariable analysis. Findings of the P2 group were artero-venous malformations (54.5%), inflammatory (23.6%) and protruding (10.4%) lesions, and luminal blood (11.5%). In this selected, prospectively collected cohort of small-bowel capsule endoscopy performed for obscure gastrointestinal bleeding, a longer small-bowel transit time was associated with a higher detection rate of significant lesions, along with age and a low center volume, with age serving as an independent predictor.
- 1 January 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 23 (4) , 697-702
Open AccessImplications of small-bowel transit time in the detection rate of capsule endoscopy: A multivariable multicenter study of patients with obscure gastrointestinal bleeding
To define the role of small-bowel transit time in the detection rate of significant small-bowel lesions. Small-bowel capsule endoscopy records, prospectively collected from 30 participating centers in the Lombardy Registry from October 2011 to December 2013, were included in the study if the clinical indication was obscure gastrointestinal bleeding and the capsule reached the cecum. Based on capsule findings, we created two groups: P2 (significant findings) and P0-1 (normal/negligible findings). Groups were compared for age, gender, small-bowel transit time, type of instrument, modality of capsule performance (outpatients vs inpatients), bowel cleanliness, and center volume. We retrieved and scrutinized 1,433 out of 2,295 capsule endoscopy records (62.4%) fulfilling the inclusion criteria. Patients were 67 ± 15 years old, and 815 (57%) were males. In comparison with patients in the P0-1 group, those in the P2 group (n = 776, 54%) were older (P < 0.0001), had a longer small-bowel transit time (P = 0.0015), and were more frequently examined in low-volume centers (P < 0.001). Age and small-bowel transit time were correlated (P < 0.001), with age as the sole independent predictor on multivariable analysis. Findings of the P2 group were artero-venous malformations (54.5%), inflammatory (23.6%) and protruding (10.4%) lesions, and luminal blood (11.5%). In this selected, prospectively collected cohort of small-bowel capsule endoscopy performed for obscure gastrointestinal bleeding, a longer small-bowel transit time was associated with a higher detection rate of significant lesions, along with age and a low center volume, with age serving as an independent predictor.
- 1 August 2016
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 28 (8) , 871-875
Short article: Negative small-bowel cross-sectional imaging does not exclude capsule retention in high-risk patients
Background and aims: Both Agile patency capsule (PC) and small-bowel cross-sectional imaging (SBCSI) techniques have been used to assess small-bowel patency in patients at high risk of capsule retention. The present study aimed to compare capsule retention rates in high-risk patients with negative PC or SBCSI. Materials and methods: Between January 2011 and December 2013, consecutive patients undergoing small-bowel capsule endoscopy (SBCE) in the Lombardia region were prospectively entered into a dedicated registry. They were classified as being at high or low risk of capsule retention by the local investigator according to predefined clinical criteria. High-risk patients underwent either PC or SBCSI depending on local expertise and availability; those who tested negative underwent SBCE. Results: Out of 3117 patients (male/female: 1667/1450, mean age: 63.1±17.7), 2942 (94.4%) were classified as being at low risk and 175 (5.6%) were classified as being at high risk for capsule retention. Among 175 high-risk patients, 151 (86.3%) had negative PC and 24 (13.7%) had negative SBCSI: capsule retention occurred in two patients with negative SBCSI (8.3%) and in one patient (0.7%) with negative PC (P=0.049). The capsule retention rates in high-risk patients with negative PC and in low-risk patients (20/2942; 0.7%) were comparable (P=1.0). Conclusion: The capsule retention rate is similar in low-risk and negative PC high-risk patients. Conversely, high-risk patients with negative SBCSI have a significantly higher capsule retention rate. Our data suggest that in high-risk patients, negative SBCSI examination is not reassuring and, when SBCE is indicated, PC should be performed.
- 1 August 2016
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 28 (8) , 871-875
Short article: Negative small-bowel cross-sectional imaging does not exclude capsule retention in high-risk patients
Background and aims: Both Agile patency capsule (PC) and small-bowel cross-sectional imaging (SBCSI) techniques have been used to assess small-bowel patency in patients at high risk of capsule retention. The present study aimed to compare capsule retention rates in high-risk patients with negative PC or SBCSI. Materials and methods: Between January 2011 and December 2013, consecutive patients undergoing small-bowel capsule endoscopy (SBCE) in the Lombardia region were prospectively entered into a dedicated registry. They were classified as being at high or low risk of capsule retention by the local investigator according to predefined clinical criteria. High-risk patients underwent either PC or SBCSI depending on local expertise and availability; those who tested negative underwent SBCE. Results: Out of 3117 patients (male/female: 1667/1450, mean age: 63.1±17.7), 2942 (94.4%) were classified as being at low risk and 175 (5.6%) were classified as being at high risk for capsule retention. Among 175 high-risk patients, 151 (86.3%) had negative PC and 24 (13.7%) had negative SBCSI: capsule retention occurred in two patients with negative SBCSI (8.3%) and in one patient (0.7%) with negative PC (P=0.049). The capsule retention rates in high-risk patients with negative PC and in low-risk patients (20/2942; 0.7%) were comparable (P=1.0). Conclusion: The capsule retention rate is similar in low-risk and negative PC high-risk patients. Conversely, high-risk patients with negative SBCSI have a significantly higher capsule retention rate. Our data suggest that in high-risk patients, negative SBCSI examination is not reassuring and, when SBCE is indicated, PC should be performed.
- Open Access
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Endoscopy
- Vol. 8 (9) , 391-4
First report of splenic rupture following deep enteroscopy
Splenic rupture is a rare complication of diagnostic and therapeutic gastrointestinal endoscopy procedures. Herein, we report for the first time a case of splenic rupture following therapeutic retrograde double-balloon enteroscopy, which occurred in an 85-year-old man who was treated for recurrent mid-intestinal bleeding that resulted from ileal angioectasia. This patient promptly underwent an operation and eventually recovered.
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Endoscopy
- Vol. 8 (9) , 391-4
Open AccessFirst report of splenic rupture following deep enteroscopy
Splenic rupture is a rare complication of diagnostic and therapeutic gastrointestinal endoscopy procedures. Herein, we report for the first time a case of splenic rupture following therapeutic retrograde double-balloon enteroscopy, which occurred in an 85-year-old man who was treated for recurrent mid-intestinal bleeding that resulted from ileal angioectasia. This patient promptly underwent an operation and eventually recovered.
- 1 October 2014
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 80 (4) , 642-651
Utility of 3-dimensional image reconstruction in the diagnosis of small-bowel masses in capsule endoscopy (with video)
- 1 October 2014
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 80 (4) , 642-651
Utility of 3-dimensional image reconstruction in the diagnosis of small-bowel masses in capsule endoscopy (with video)
- 25 September 2014
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 9 (8) , 871-874
Currently neglected, physical examination maintains its clinical relevance
- 25 September 2014
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 9 (8) , 871-874
Currently neglected, physical examination maintains its clinical relevance
- Open Access
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (9) , 613-616
Small-bowel myeloid sarcoma: Report of a case with atypical presentation
Small-bowel myeloid sarcoma is rare. Acute bowel obstruction is its usual clinical presentation. We report a case of small-bowel myeloid sarcoma that occurred in a 64-year-old woman who presented chronic secretory diarrhoea, hypokalaemia, and weight loss. Immature white blood cells in a peripheral smear and small-bowel capsule endoscopic features were the main diagnostic clues. The patient experienced capsule retention and developed acute bowel obstruction. Urgent laparotomy showed a stricturing ileal mass and pathology of the resected bowel specimen unveiled a CD34+, CD117+, and myeloperoxidase-positive myeloid sarcoma. The diarrhoea promptly resolved after surgery, and the patient is now undergoing chemotherapy. Secretory diarrhoea can be the first manifestation of small-bowel myeloid sarcoma. Capsule endoscopy may provide a diagnostic clue, but it can trigger an acute bowel obstruction. Differential diagnosis of the pathologic specimen may be difficult and a high suspicion index of is mandatory to perform immunophenotyping to determine the correct management. Chronic diarrhoea with alarm features can be the first manifestation of small-bowel myeloid sarcoma.
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (9) , 613-616
Open AccessSmall-bowel myeloid sarcoma: Report of a case with atypical presentation
Small-bowel myeloid sarcoma is rare. Acute bowel obstruction is its usual clinical presentation. We report a case of small-bowel myeloid sarcoma that occurred in a 64-year-old woman who presented chronic secretory diarrhoea, hypokalaemia, and weight loss. Immature white blood cells in a peripheral smear and small-bowel capsule endoscopic features were the main diagnostic clues. The patient experienced capsule retention and developed acute bowel obstruction. Urgent laparotomy showed a stricturing ileal mass and pathology of the resected bowel specimen unveiled a CD34+, CD117+, and myeloperoxidase-positive myeloid sarcoma. The diarrhoea promptly resolved after surgery, and the patient is now undergoing chemotherapy. Secretory diarrhoea can be the first manifestation of small-bowel myeloid sarcoma. Capsule endoscopy may provide a diagnostic clue, but it can trigger an acute bowel obstruction. Differential diagnosis of the pathologic specimen may be difficult and a high suspicion index of is mandatory to perform immunophenotyping to determine the correct management. Chronic diarrhoea with alarm features can be the first manifestation of small-bowel myeloid sarcoma.
- Open Access
- 1 June 2013
- Published by Elsevier in Video Journal and Encyclopedia of GI Endoscopy
- Vol. 1 (1) , 284-285
The PillCam Detection of Meckel's Diverticulum
- 1 June 2013
- Published by Elsevier in Video Journal and Encyclopedia of GI Endoscopy
- Vol. 1 (1) , 284-285
Open AccessThe PillCam Detection of Meckel's Diverticulum